tirzepatide protein (TZP) is a 39-amino acid peptide composed of both native Tirzepatide shows 98.7% diabetes prevention

Adherence remains a significant challenge over time

Retatrutide is a triple agonist (GLP-1/GIP/Glucagon) delivering 28.7% weight loss but is investigational with higher discontinuation (11.318.2% depending on trial)

Pfizer has said it expects pills to eventually capture about a third of the obesity drug market, which is predicted to grow to about $130 billion by the end of the decade

Regular fluid intake is important, particularly if diarrhoea or vomiting occurs to avoid the risk of dehydration

Foods rich in NAD+ primarily boost its precursors in the body, as direct dietary sources of NAD+ are limited

Understanding the potential side effects of each medication helps patients recognise normal responses versus concerning symptoms requiring medical attention